List

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until April, 2020.

  1. Long Range ROW Detection and Warning System

    SBC: R-DEX Systems, Inc            Topic: 151FR7

    R-DEX Systems proposes to develop the TrackMap System, an innovative and groundbreaking long-range detection and warning system (DWS) for the detection of unlawful targets on the railroad right of way (ROW). TrackMap will leverage low-cost radar sensors, proven software, and high-performance embedded processing to enable the Federal Railroad Administration (FRA) and its safety partners to signific ...

    SBIR Phase I 2015 Department of Transportation
  2. Reducing Cost, Improving Efficiency and Safety of Farming Crickets as Food Ingredients

    SBC: ALL THINGS BUGS LLC            Topic: 812

    N/A

    SBIR Phase I 2015 Department of Agriculture
  3. Biological feedback control of LED grow lights

    SBC: PhytoSynthetix            Topic: 813

    In controlled environment agricultural (CEA) systems (greenhouses and indoor plant production facilities) light is the most energy consuming, and yet the least controlled, input factor for plant growth. Plants can dissipate up to 80% of the absorbed light energy as heat through physiological protective mechanisms (non photochemical quenching) and this light cannot be used for plant growth. Light e ...

    SBIR Phase I 2015 Department of Agriculture
  4. IGF OT IGF TITLE CHEMO ENZYMATIC SYNTHESIS OF STRUCTURALLY DEFINED COMPLEX TYPE N GLYCANS

    SBC: CHEMILY, LLC            Topic: NCI

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  5. Antibody Secretig Cells ASC in Human Colostridium difficile Infection Colonization and Recurrence

    SBC: MICROBPLEX, INC.            Topic: ODCDC

    The objective of this proposal is the creation of a method for identifying patients with hospital acquired C difficile infections likely to suffer expensive and potentially life threatening recurrences after discharge from the hospital C difficile has emerged as the biggest infectious killer of Americans as well as a multi billion drain on the health care system Most of those costs and mort ...

    SBIR Phase II 2015 Department of Health and Human Services
  6. High-specificity affinity reagents for the detection of glycan sialylation

    SBC: GLYCOSENSORS AND DIAGNOSTICS, LLC            Topic: 300

    DESCRIPTION provided by applicant Glycans have several distinct properties that make their development as disease biomarkers appealing Firstly their location on cell surfaces makes them the first point of contact for cellular interactions and thus they are crucial in the control of normal metabolic processes and conversely they function as pathogen adhesion receptors Secondly specific gl ...

    STTR Phase I 2015 Department of Health and Human Services
  7. Development of Isotopically Labeled Glycoproteins for use as Internal Standards

    SBC: GlycoScientific, L.L.C.            Topic: 300

    DESCRIPTION provided by applicant The ability to accurately quantitate the glycan chains attached to glycoproteins has wide ranging implications Numerous studies over the past years have demonstrated that abnormal glycosylation occurs in virtually all types of human cancers and demonstrate the potential of using glycan markers in either a diagnostic or a prognostic manner The glycosylatio ...

    STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  8. Manufacturing pathogen inactivated platelet lysate to treat corneal inflammation

    SBC: Cambium Medical Technologies LLC            Topic: N

    DESCRIPTION provided by applicant Ocular graft versus host disease O GVHD is a particularly severe and debilitating complication of allogeneic hematopoietic stem cell transplantation HSCT O GVHD develops in of patients with chronic GVHD Currently Restasis cyclosporine A is the only FDA approved prescription topical medication to treat O GVHD In Restasis had sales o ...

    STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  9. Selenium-derivatized New Reagents for Nucleic Acid X-ray Crystallography

    SBC: SENA RESEARCH, INC.            Topic: NIEHS

    DESCRIPTION provided by applicant There are growing demands for D structure determination of nucleic acids and their protein complexes for understanding disease molecule level mechanisms and discovering innovative drugs X ray crystallography is one of the most direct and powerful tools for structure determination of these macromolecules and complexes However the crystallization and phase d ...

    STTR Phase II 2015 Department of Health and Human Services
  10. Anti-CXCL13 mAb to mitigate prostate cancer health disparities

    SBC: JYANT Technologies, Inc.            Topic: NIMHD

    DESCRIPTION provided by applicant The most common metastatic site for hormone refractory prostate cancer HRPC PCa is bone While docetaxel can prolong the overall survival in patients with metastatic HRPC current treatments do not provide a cure Further complicating the matter HRPC is a disease that affects a variety of patients differently which can be problematic for physicians to prov ...

    STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government